Non-Opioid Pain Patch Global Market Report 2025

Description

A non-opioid pain patch is a topical treatment designed to manage pain without the use of opioids. This non-systemic option is unique in providing prescription-strength relief. The patch delivers non-addictive medication directly to the affected area through the skin, allowing for effective pain management while reducing the risk of addiction and side effects associated with opioids. It is typically used to alleviate mild to moderate pain.

The primary types of non-opioid pain patches include lidocaine patches, diclofenac patches, capsaicin patches, ketoprofen patches, and others. Lidocaine patches, for instance, are transdermal patches with analgesic properties. These patches are composed of a synthetic amide-type anesthetic, lidocaine, formulated in a 5 percent aqueous base solution. They serve the purpose of aiding in the treatment of itching and pain associated with certain skin disorders. Lidocaine patches are distributed through various channels, including hospital pharmacies, retail pharmacies, and other outlets. These patches find applications in treating various conditions, including musculoskeletal pain and neuropathic pain.

The non-opioid pain patch research report is one of a series of new reports from The Business Research Company that provides non-opioid pain patch market statistics, including the non-opioid pain patch industry's global market size, regional shares, competitors with non-opioid pain patch market share, detailed non-opioid pain patch market segments, market trends and opportunities, and any further data you may need to thrive in the non-opioid pain patch industry. This non-opioid pain patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The non-opioid pain patch market size has grown strongly in recent years. It will grow from $3.48 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increased chronic pain cases, patient preference for non-invasive treatment, improved formulations and ingredients, rise in sports injuries, and concerns over opioid addiction

The non-opioid pain patch market size is expected to see strong growth in the next few years. It will grow to $4.5 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing R&D investment, rising healthcare expenditure, a supportive regulatory environment, consumer awareness and education, and an expanding geriatric population. Major trends in the forecast period include wireless and smart patch technologies, integration of natural ingredients, integration with wearable technology, biodegradable and eco-friendly patches, and focus on long-lasting effects.

The increasing prevalence of chronic pain is anticipated to drive the growth of the non-opioid pain patch market in the coming years. Chronic pain is characterized by severe discomfort that persists for an extended period or occurs alongside another medical condition. Non-opioid pain patches are effective for alleviating mild to moderate pain, including headaches, muscle aches, arthritis, backaches, and various other pain types. For example, in November 2023, Eurostat, a government agency based in Luxembourg, reported that in 2022, over one-third (36.1%) of individuals in the EU indicated they had a long-term (chronic) health condition. Thus, the rising prevalence of chronic pain is boosting the non-opioid pain patch market.

Increasing research and development activities are projected to further propel the growth of the non-opioid pain patch market. Research and development (R&D) encompass the investigative efforts by a company or organization aimed at enhancing existing products and procedures or creating new ones. The advancement of non-opioid pain management solutions, particularly through patches, has emerged as a dynamic field for R&D, largely due to heightened concerns regarding opioid dependence and associated side effects. For instance, in January 2024, the National Center for Science and Engineering Statistics (NCSES), a US-based statistical agency under the National Science Foundation, noted that research and experimental development (R&D) expenditures in the United States reached $789.1 billion in 2021, with an estimated total of $885.6 billion for 2022. Therefore, the increase in research and development activities is driving the growth of the non-opioid pain patch market.

Product innovation is emerging as a prominent trend gaining traction in the non-opioid pain patch market, with major companies actively developing innovative solutions to enhance their market positions. An illustrative example is The Mentholatum Company Inc., a UK-based healthcare products manufacturer, which introduced the Deep Relief Actiflex Patch in June 2022. This drug-free pain patch features a cooling hydrogel containing water, offering fast cooling and soothing relief as the water evaporates on the skin. Specifically designed to treat aches and pains in muscles or joints, this innovative patch adds diversity to the non-opioid pain patch market.

Key players in the non-opioid pain patch market are focusing on the development of innovative products, including genetically validated target medicines. This approach involves creating drugs that specifically target biological pathways associated with diseases, guided by robust genetic evidence. Such a strategy enhances the effectiveness of treatments while minimizing the risk of side effects. For instance, in February 2024, Latigo Biotherapeutics Inc., a US-based biotechnology firm, introduced LTG-001, a selective inhibitor of the Nav1.8 sodium channel predominantly found in peripheral nerve cells. By targeting this specific channel, LTG-001 aims to interrupt pain signals at their origin, potentially offering effective pain relief without impacting the central nervous system. The results from Phase 1 clinical trials indicated that LTG-001 has a Tmax (time to maximum concentration) of approximately 1.5 hours, which implies a rapid onset of pain relief. This characteristic is particularly significant for managing both acute and chronic pain. Furthermore, LTG-001 is formulated for oral administration, providing a more convenient option for patients compared to injectable or topical treatments, thus enhancing compliance and ease of use.

In January 2024, Heron Therapeutics, a US-based biotechnology company specializing in non-opioid pain medications, formed a partnership with CrossLink Life Sciences. The goal of this collaboration is to broaden the sales network for ZYNRELEF, a pain-relief solution designed for orthopedic surgeries, throughout the United States. This partnership aims to increase product adoption, streamline access, and enhance post-operative pain management for a greater number of patients. CrossLink Life Sciences is a US-based private distributor specializing in orthopedic, spine, and sports medicine devices.

Major companies operating in the non-opioid pain patch market include Hisamitsu Pharmaceutical Co., Inc., Teikoku Pharma USA, Inc., Purdue Pharma L.P., Noven Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Grunenthal GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Medtronic plc, Abbott Laboratories, Bayer AG, Iroko Pharmaceuticals, LLC, Scilex Pharmaceuticals Inc., Zosano Pharma Corporation, Adynxx Inc., BioElectronics Corporation, NeuroMetrix Inc., Virpax Pharmaceuticals Inc., Eli Lilly and Company, Novartis AG, Amgen Inc., DURECT Corporation

North America was the largest region in the non-opioid pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-opioid pain patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-opioid pain patch market consists of sales of aspirin, ibuprofen, and acetaminophen patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Opioid Pain Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-opioid pain patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-opioid pain patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-opioid pain patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Patch: Lidocaine Patches; Diclofenac Patches; Capsaicin Patches; Ketoprofen Patches; Other Patches
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
3) By Indication: Musculoskeletal Pain; Neuropathic Pain
Subsegments:
1) By Lidocaine Patches: 5% Lidocaine Patch; Other Concentrations
2) By Diclofenac Patches: 1.3% Diclofenac Patch; Other Concentrations
3) By Capsaicin Patches: 8% Capsaicin Patch; Other Concentrations
4) By Ketoprofen Patches: 5% Ketoprofen Patch; Other Concentrations
5) By Other Patches: Combination Patches; Herbal Extract Patches; Other Non-Opioid Patches
Companies Mentioned: Hisamitsu Pharmaceutical Co., Inc.; Teikoku Pharma USA, Inc.; Purdue Pharma L.P.; Noven Pharmaceuticals, Inc.; Johnson & Johnson Services, Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25148

1. Executive Summary

2. Non-Opioid Pain Patch Market Characteristics

3. Non-Opioid Pain Patch Market Trends And Strategies

4. Non-Opioid Pain Patch Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Non-Opioid Pain Patch Growth Analysis And Strategic Analysis Framework

5.1. Global Non-Opioid Pain Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Non-Opioid Pain Patch Market Growth Rate Analysis
5.4. Global Non-Opioid Pain Patch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Non-Opioid Pain Patch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Non-Opioid Pain Patch Total Addressable Market (TAM)

6. Non-Opioid Pain Patch Market Segmentation

6.1. Global Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fully Processed
Semi-processed
6.2. Global Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
0.35 mm
0.5 mm
0.65 mm
Other Thickness
6.3. Global Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inductors
Transformers
Motors
Other Applications
6.4. Global Non-Opioid Pain Patch Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automotive Industry
Aviation
Power
Domestic Appliances
Other End Users
6.5. Global Non-Opioid Pain Patch Market, Sub-Segmentation Of Fully Processed, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cold Rolled Electrical Steel
Hot Rolled Electrical Steel
6.6. Global Non-Opioid Pain Patch Market, Sub-Segmentation Of Semi-Processed, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cold Rolled Non-Grain Oriented Steel
Hot Rolled Non-Grain Oriented Steel

7. Non-Opioid Pain Patch Market Regional And Country Analysis

7.1. Global Non-Opioid Pain Patch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Non-Opioid Pain Patch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Non-Opioid Pain Patch Market

8.1. Asia-Pacific Non-Opioid Pain Patch Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Non-Opioid Pain Patch Market

9.1. China Non-Opioid Pain Patch Market Overview
9.2. China Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Non-Opioid Pain Patch Market

10.1. India Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Non-Opioid Pain Patch Market

11.1. Japan Non-Opioid Pain Patch Market Overview
11.2. Japan Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Non-Opioid Pain Patch Market

12.1. Australia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Non-Opioid Pain Patch Market

13.1. Indonesia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Non-Opioid Pain Patch Market

14.1. South Korea Non-Opioid Pain Patch Market Overview
14.2. South Korea Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Non-Opioid Pain Patch Market

15.1. Western Europe Non-Opioid Pain Patch Market Overview
15.2. Western Europe Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Non-Opioid Pain Patch Market

16.1. UK Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Non-Opioid Pain Patch Market

17.1. Germany Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Non-Opioid Pain Patch Market

18.1. France Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Non-Opioid Pain Patch Market

19.1. Italy Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Non-Opioid Pain Patch Market

20.1. Spain Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Non-Opioid Pain Patch Market

21.1. Eastern Europe Non-Opioid Pain Patch Market Overview
21.2. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Non-Opioid Pain Patch Market

22.1. Russia Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Non-Opioid Pain Patch Market

23.1. North America Non-Opioid Pain Patch Market Overview
23.2. North America Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Non-Opioid Pain Patch Market

24.1. USA Non-Opioid Pain Patch Market Overview
24.2. USA Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Non-Opioid Pain Patch Market

25.1. Canada Non-Opioid Pain Patch Market Overview
25.2. Canada Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Non-Opioid Pain Patch Market

26.1. South America Non-Opioid Pain Patch Market Overview
26.2. South America Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Non-Opioid Pain Patch Market

27.1. Brazil Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Non-Opioid Pain Patch Market

28.1. Middle East Non-Opioid Pain Patch Market Overview
28.2. Middle East Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Non-Opioid Pain Patch Market

29.1. Africa Non-Opioid Pain Patch Market Overview
29.2. Africa Non-Opioid Pain Patch Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Non-Opioid Pain Patch Market, Segmentation By Thickness, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Non-Opioid Pain Patch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Non-Opioid Pain Patch Market Competitive Landscape And Company Profiles

30.1. Non-Opioid Pain Patch Market Competitive Landscape
30.2. Non-Opioid Pain Patch Market Company Profiles
- 30.2.1. ThyssenKrupp AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. ArcelorMittal SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Pohang Iron and Steel Company (POSCO) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Nippon Steel Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Ansteel Group Corporation Limited Overview, Products and Services, Strategy and Financial Analysis

31. Non-Opioid Pain Patch Market Other Major And Innovative Companies

31.1. Shagang Group Co. Ltd.
31.2. Shougang Group Co. Ltd.
31.3. Baosteel Group Corporation
31.4. JFE Holdings Inc.
31.5. Tata Steel Limited
31.6. United States Steel Corporation
31.7. Voestalpine AG
31.8. NoVo Lipetsk Steel
31.9. Benxi Steel Group Co. Ltd
31.10. Aperam S.A.
31.11. China BaoWu Steel Group Corporation Limited
31.12. Taiyuan Iron and Steel Co. Ltd.
31.13. Malaysia Steel Works (KL) Bhd.
31.14. CSC Steel Sdn. Bhd.
31.15. Arnold Magnetic Technologies Corporation

32. Global Non-Opioid Pain Patch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Non-Opioid Pain Patch Market

34. Recent Developments In The Non-Opioid Pain Patch Market

35. Non-Opioid Pain Patch Market High Potential Countries, Segments and Strategies

35.1 Non-Opioid Pain Patch Market In 2029 - Countries Offering Most New Opportunities
35.2 Non-Opioid Pain Patch Market In 2029 - Segments Offering Most New Opportunities
35.3 Non-Opioid Pain Patch Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer